CG
RDY icon

Colony Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Colony Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-29,680
Closed -$275K – 540
2015
Q4 		$275K Sell
29,680
-3,175
-10% -$34.8K 0.03% 326
2015
Q3 		$420K Sell
32,855
-665
-2% -$8.26K 0.05% 260
2015
Q2 		$371K Buy
33,520
+5,800
+21% +$64K 0.04% 277
2015
Q1 		$317K Buy
27,720
+4,420
+19% +$46.9K 0.04% 248
2014
Q4 		$235K Buy
+23,300
New +$245K 0.02% 315

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Colony Group's RDY Position: Q1 2016 in Review

Colony Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 29,680 shares — an estimated $275K sold.

Colony Group first reported a position in RDY in Q4 2014 and held it in 5 quarters. The position peaked at $420K in Q3 2015. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

  • Colony Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 29,680 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $275K.
  • Colony Group first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 5 quarters.
  • Colony Group's Dr. Reddy's Laboratories position peaked at $420K in Q3 2015.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.